Testing effectiveness (Phase 2)Study completedNCT00997386
What this trial is testing
Reduced Intensity Allogeneic PBSCT to Treat Hematologic Malignancies and Hematopoietic Failure States
Who this might be right for
Hematologic NeoplasmsMultiple MyelomaAnemia, Aplastic+2 more
University of Arizona 16